This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1. C Gianfrani , S Auricchio & R Troncone (2005) Adaptive and innate immune responses in celiac disease. Immunol Lett 99, 141–145.
2. B Meresse , J Ripoche , M Heyman (2009) Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol 2, 8–23.
3. S Guandalini & M Setty (2008) Celiac disease. Curr Opin Gastroenterol 24, 707–712.
4. DA Van Heel , K Hunt , L Greco (2005) Genetics in celiac disease. Best Pract Res Clin Gastroenterol 19, 323–339.
5. O Molberg , SN Mcadam , R Körner (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4, 713–717.
7. M Ráki , S Tollefsen , Ø Molberg (2006) A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131, 428–438.
8. AL de Kauwe , Z Chen , RP Anderson (2009) Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J Immunol 182, 7440–7450.
9. KE Black , JA Murray & CS David (2002) HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 169, 5595–5600.
10. R D'Arienzo , F Maurano , D Luongo (2008) Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity. Immunol Lett 119, 78–83.
11. T Kutlu , N Brousse , C Rambaud (1993) Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 34, 208–214.
12. G Bhagat , AJ Naiyer , JG Shah (2008) Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest 118, 281–293.
13. B Meresse , Z Chen , C Ciszewski (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357–366.
14. S Hüe , JJ Mention , RC Monteiro (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367–377.
15. L Maiuri , C Ciacci , I Ricciardelli (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362, 30–37.
16. A Di Sabatino , R Ciccocioppo , F Cupelli (2006) Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55, 469–477.
17. G Monteleone , SL Pender , E Alstead (2001) Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48, 425–429.
18. LC Stene , MC Honeyman , EJ Hoffenberg (2006) Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 101, 2333–2340.
19. L Plot & H Amital (2009) Infectious associations of Celiac disease. Autoimmun Rev 8, 316–319.
20. G Zanoni , R Navone , C Lunardi . (2006) In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 3, e358.
22. B Szebeni , G Veres , A Dezsofi (2007) Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease. J Pediatr Gastroenterol Nutr 45, 187–193.
23. AK Akobeng , AV Ramanan , I Buchan (2006) Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 91, 39–43.
25. A Ivarsson , LA Persson , L Nyström . (2000) Epidemic of coeliac disease in Swedish children. Acta Paediatr 89, 165–171.
26. A Myléus , A Ivarsson , C Webb (2009) Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 49, 170–176.
28. R Troncone , A Ivarsson , H Szajewska (2008) Members of European Multistakeholder Platform on CD (CDEUSSA) (2008) Review article: future research on coeliac disease - a position report from the European multistakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther 27, 1030–1043.
29. JM Norris , K Barriga , EJ Hoffenberg (2005) Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293, 2343–2351.
30. KM Lammers , R Lu , J Brownley (2008) Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135, 194–204.
31. C Agostoni , T Decsi , M Fewtrell ESPGHAN Committee on Nutrition (2008) Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 46, 99–110.
32. C Agostoni , C Braegger , T Decsi ESPGHAN Committee on Nutrition (2009) Breast-feeding: A Commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 49, 112–125.
33. AM Mowat , AM Faria & HL Weiner (2005) Oral tolerance: basic mechanisms and clinical implications. In Mucosal immunology, 3rd ed., pp. 487–538 [ J Mestecky , J Bienenstock and ME Lamm , editors]. San Diego, CA: Academic Press.
34. TT Macdonald & G Monteleone (2005) Immunity, inflammation, and allergy in the gut. Science 307, 1920–1925.
35. AM Mowat , LA Parker , H Beacon-Sharp (2004) Oral tolerance: overview and historical perspectives. Ann NY Acad Sci 1029, 1–8.
36. N Cools , P Ponsaerts , VF Van Tendeloo (2007) Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 82, 1365–1374.
37. P Guermonprez , J Valladeau , L Zitvogel (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20, 621.
38. S Strobel & AM Mowat (2006) Oral tolerance and allergic responses to food proteins. Curr Opin Allergy Clin Immunol 6, 207–213.
39. JL Lowrey , ND Savage , D Palliser (1998) Induction of tolerance via the respiratory mucosa. Int Arch Allergy Immunol 116, 93–102.
40. S Senger , D Luongo , F Maurano (2003) Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol Lett 88, 127–134.
41. A Fasano , M Araya , S Bhatnagar (2008) Celiac Disease Working Group, FISPGHAN. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr 47, 214–219.
43. M Brenner , T Laragione , NC Yarlett (2007) Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat. Mol Med 13, 277–287.
44. B Bisikirska , J Colgan , J Luban (2005) TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 115, 2904–2913.
45. DA Van Heel , L Franke , KA Hunt (2007) A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 39, 827–829.
46. TO Kerttula , P Collin , A Polvi (1996) Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and QB1*0201. Alterations in circulating T cell receptor gamma/delta subsets. Arthritis Rheum 39, 1733–1739.
48. I Nadal , E Donat , C Ribes-Koninckx (2007) Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 56(Pt 12), 1669–1674.
49. R Menningen & M Bruewer (2009) Effect of probiotics on intestinal barrier function. Ann NY Acad Sci 1165, 183–189.
50. M Rossi , F Maurano & D Luongo (2005) Immunomodulatory strategies for celiac disease. Int Rev Immunol 24, 479–499.
51. C Gianfrani , RA Siciliano , AM Facchiano (2007) Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133, 780–789.
52. J Xia , E Bergseng , B Fleckenstein (2007) Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease. Bioorg Med Chem 15, 6565–6573.
53. JS Fraser , W Engel , HJ Ellis (2003) Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 52, 1698–1702.
54. D Branski , A Fasano & R Troncone (2006) Latest developments in the pathogenesis and treatment of celiac disease. J Pediatr 149, 295–300.
55. M Silano , O Vincentini , A Iapello (2008) Antagonist peptides of the gliadin T cell stimulatory sequences: a therapeutic strategy for celiac disease. J Clin Gastroenterol 42, Suppl 3, Pt 2, S191–S192.
56. VV Kapoerchan , M Wiesner , M Overhand (2008) Design of azidoproline containing gluten peptides to suppress CD4+ T cell responses associated with celiac disease. Bioorg Med Chem 16, 2053–2062.
57. D Stepniak , L Spaenij-Dekking , C Mitea (2006) Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol 291, G621–G629.
58. J Ehren , S Govindarajan , B Morón (2008) Protein engineering of improved prolyl endopeptidases for celiac sprue therapy. Protein Eng Des Sel 21, 699–707.